Alternative Pain Therapy for Breast, Prostate and Lung Cancer
MIAMI–BUSINESS WIRE — Bio-Nucleonics’ lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in [...]
read moreBio-Nucleonics Continues Production of Cancer Drug
MIAMI–(BUSINESS WIRE)–Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011. The Company announced that it has resumed production of the cancer drug Strontium Chloride Sr-89 Injection [...]
read morePreliminary Application Of Strontium-89 For The Treatment Of Bone Metastases From Prostate Cancer
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Dec;27(6):1251-4. Zhao W, Deng H, Jie P, Qing C, Zhang X. Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu 610041, China. Abstract Bone metastases are a major problem in the clinical management of patients with prostate cancer. Despite the use of analgesic for the relief [...]
read moreInformation is for End User's use only and may not be sold,
redistributed or otherwise used for commercial purposes.
